Active Biotech
0.06 SEK
-2.26 %
Less than 1K followers
ACTI
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Active Biotech
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 8.4 | 6.7 | |||||
| growth-% | -20.2 % | ||||||
| EBITDA | -30.5 | -31.0 | -47.2 | -55.7 | -44.7 | -38.1 | -36.0 |
| EBIT | -32.3 | -32.3 | -48.5 | -57.9 | -46.5 | -39.8 | -37.6 |
| Profit before taxes | -34.1 | -32.2 | -48.6 | -58.4 | -45.8 | -39.4 | -37.3 |
| Net income | -34.1 | -32.2 | -48.6 | -58.4 | -45.8 | -39.4 | -37.3 |
| EPS | -0.06 | -0.07 | -0.07 | -0.08 | -0.06 | -0.07 | -0.03 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -363.1 % | -462.7 % | |||||
| EBIT-% | -384.5 % | -482.1 % | |||||
| ROE | -63.4 % | -145.7 % | -101.5 % | -169.3 % | -149.2 % | -120.5 % | -67.1 % |
| ROI | -50.9 % | -100.0 % | -85.6 % | -114.5 % | -104.1 % | -91.2 % | -53.1 % |